Sign in
Taking people in NetherlandsPhase 4

Tests statins in frail older people after a stroke or mini-stroke

Compares starting a statin with no statin in frail older adults after stroke or TIA.

Key facts

Who runs it
Amsterdam UMC Stichting
Where
'S-Gravenhage, 'S-Hertogenbosch, Almere, Amsterdam, Apeldoorn, Arnhem, Eindhoven, Enschede, Groningen, Heerlen, Helmond, Leeuwarden, Leiden, Maastricht, Nieuwegein, Rotterdam, Tilburg, Utrecht, Venlo, and Zwolle, NetherlandsSee the 23 sites
Registry title
StAtins in Frail oldEr patients with ischemic Stroke or Transient ischemic attack – The Randomized Controlled Trial
Status
Recruiting
Phase
Phase 4
People taking part
600 people, planned
Started
11 Apr 2025
Expected to end
1 Oct 2029
Type of study
Interventional
Record updated
17 December 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for frail people aged 70 or older who recently had an ischemic stroke or a transient ischemic attack (TIA) and do not take a statin.

Age
70 years or older at the time of the stroke or TIA.
Sex
All sexes can join.
Disease stage
Ischemic stroke or TIA within the 6 weeks before joining. Frailty on the Clinical Frailty Scale: a score of 4-7 before the event and/or 6-7 after the event.
Earlier treatment
Must not have been taking statin therapy at the time of the stroke or TIA.

Main reasons for not taking part

  • Serious side effects from statins in the past, or another reason statins cannot be used
  • Very severe frailty or life expectancy under 6 months (score of 8 or more on the Clinical Frailty Scale)
  • Cannot communicate in Dutch
  • Cannot answer questions, even with the help of a proxy
  • Cannot or does not want to give written informed consent, even with the help of a proxy

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • A recent ischemic stroke or TIA (within 6 weeks before inclusion)
  • Age equal to or greater than 70 years at the time of the ischemic stroke or TIA
  • Frailty, as defined by a pre-event score of 4-7 and/or a post-event score of 6-7 on the validated Clinical Frailty Scale
  • Not using statin therapy at the time of the index event

Who cannot take part

  • Previous serious adverse drug reactions (defined as an adverse reaction that results in death, is life-threatening, requires hospitalization or prolongation of existing hospitaliza-tion, results in persistent or significant disability or incapacity, or is a birth defect) to statins or other contraindications to statin use
  • Very severe frailty or very limited life expectancy (< 6 months) as defined by a score >= 8 points on the validated Clinical Frailty Scale
  • Inability to communicate in Dutch
  • Inability to respond to questions, either independently or with the assistance of a proxy
  • Inability or unwillingness to provide written informed consent, either independently or with the assistance of a proxy

Where in Netherlands

  • Haaglanden Medisch Centrum Stichting'S-Gravenhage, NetherlandsTaking people
  • Jeroen Bosch Ziekenhuis Stichting'S-Hertogenbosch, NetherlandsTaking people
  • Flevoziekenhuis StichtingAlmere, NetherlandsTaking people
  • Amsterdam UMC StichtingAmsterdam, NetherlandsTaking people
  • Stichting OLVGAmsterdam, NetherlandsTaking people
  • Gelre HospitalsApeldoorn, NetherlandsTaking people
  • Rijnstate Ziekenhuis StichtingArnhem, NetherlandsTaking people
  • Catharina Ziekenhuis StichtingEindhoven, NetherlandsTaking people
  • Medisch Spectrum TwenteEnschede, NetherlandsTaking people
  • UMC GroningenGroningen, NetherlandsTaking people
  • Zuyderland Medisch Centrum StichtingHeerlen, NetherlandsTaking people
  • Elkerliek ziekenhuisHelmond, NetherlandsTaking people
  • Frisius MCLeeuwarden, NetherlandsTaking people
  • Leids Universitair Medisch Centrum (LUMC)Leiden, NetherlandsTaking people
  • Academisch Ziekenhuis MaastrichtMaastricht, NetherlandsTaking people
  • St. Antonius ZiekenhuisNieuwegein, NetherlandsTaking people
  • Erasmus Medisch Centrum 1Rotterdam, NetherlandsTaking people
  • Maasstad Ziekenhuis StichtingRotterdam, NetherlandsTaking people
  • Sint Franciscus Vlietland Groep StichtingRotterdam, NetherlandsTaking people
  • Stichting Elisabeth-TweeSteden ZiekenhuisTilburg, NetherlandsTaking people
  • Universitair Medisch Centrum UtrechtUtrecht, NetherlandsTaking people
  • Stichting Viecuri Medisch Centrum voor Noord-LimburgVenlo, NetherlandsTaking people
  • Isala Klinieken StichtingZwolle, NetherlandsTaking people

About the trial

What the trial wants to find out

To evaluate the effect of initiating statin therapy versus no statin therapy on Major Adverse Cardiovascular Events (MACE)-free survival and health-related quality of life (HRQoL) over a two-year follow-up in frail individuals aged 70 and above with a recent ischemic stroke or TIA.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
Official title
StAtins in Frail oldEr patients with ischemic Stroke or Transient ischemic attack – The Randomized Controlled Trial
Plain-language title
Tests statins in frail older people after a stroke or mini-strokeGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 9 November 2026.
Record updated
17 December 2025